AbstractThe focal adhesion protein VASP, a possible link between signal transduction pathways and the microfilament system, is phosphorylated by both cAMP- and cGMP-dependent protein kinases in vitro and in intact cells. Here, the analysis of VASP dephosphorylation by the serine/threonine protein phosphatases (PP) PP1, PP2A, PP2B and PP2C in vitro is reported. The phosphatases differed in their selectivity with respect to the dephosphorylation of individual VASP phosphorylation sites. Incubation of human platelets with okadaic acid, a potent inhibitor of PP1 and PP2A, caused the accumulation of phosphorylated VASP indicating that the phosphorylation status of VASP in intact cells is regulated to a major extent by serine/ threonine protein p...
Background Platelet adhesion to von Willebrand factor (VWF) is modulated by 3′,5′-cyclic adenosine m...
Platelet activation initiates a series of events, such as shape change, degranulation and aggregatio...
Endothelial cells release prostacyclin (PGI2) and nitric oxide (NO) to inhibit platelet functions. P...
Vasoactive agents which elevate either cGMP or cAMP inhibit platelet activation by pathways sharing ...
AbstractVasodilator-stimulated phosphoprotein (VASP), an actin binding protein localized to areas of...
Abstract: Vasodilator-stimulated phosphoprotein (VASP) is a cAMP-dependent protein kinase A (PKA) su...
Abstract: Vasodilator-stimulated phosphoprotein (VASP) is a cAMP-dependent protein kinase A (PKA) su...
Members of the vasodilator-stimulated phosphoprotein (VASP) family are important regulators of actin...
Platelet adhesion and activation at the vascular wall are the initial steps leading to arterial thro...
Sepsis-induced renal failure is associated with damage to the proximal epithelial tubule and is asso...
Clopidogrel hat sich als potentes Medikament zur Verhinderung kardiovaskulärer Ereignisse sowohl bei...
Das Vasodilatator stimulierte Phosphoprotein (VASP) ist ein Zytoskelett-assoziiertes Protein der Ena...
Members of the enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) family are important regulat...
cGMP- and cAMP-dependent protein kinases (cGK and cAK) mediate the inhibitory effects of endothelium...
The cell cycle is controlled by microtubule-associated serine/threonine kinase-like (MASTL), which p...
Background Platelet adhesion to von Willebrand factor (VWF) is modulated by 3′,5′-cyclic adenosine m...
Platelet activation initiates a series of events, such as shape change, degranulation and aggregatio...
Endothelial cells release prostacyclin (PGI2) and nitric oxide (NO) to inhibit platelet functions. P...
Vasoactive agents which elevate either cGMP or cAMP inhibit platelet activation by pathways sharing ...
AbstractVasodilator-stimulated phosphoprotein (VASP), an actin binding protein localized to areas of...
Abstract: Vasodilator-stimulated phosphoprotein (VASP) is a cAMP-dependent protein kinase A (PKA) su...
Abstract: Vasodilator-stimulated phosphoprotein (VASP) is a cAMP-dependent protein kinase A (PKA) su...
Members of the vasodilator-stimulated phosphoprotein (VASP) family are important regulators of actin...
Platelet adhesion and activation at the vascular wall are the initial steps leading to arterial thro...
Sepsis-induced renal failure is associated with damage to the proximal epithelial tubule and is asso...
Clopidogrel hat sich als potentes Medikament zur Verhinderung kardiovaskulärer Ereignisse sowohl bei...
Das Vasodilatator stimulierte Phosphoprotein (VASP) ist ein Zytoskelett-assoziiertes Protein der Ena...
Members of the enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) family are important regulat...
cGMP- and cAMP-dependent protein kinases (cGK and cAK) mediate the inhibitory effects of endothelium...
The cell cycle is controlled by microtubule-associated serine/threonine kinase-like (MASTL), which p...
Background Platelet adhesion to von Willebrand factor (VWF) is modulated by 3′,5′-cyclic adenosine m...
Platelet activation initiates a series of events, such as shape change, degranulation and aggregatio...
Endothelial cells release prostacyclin (PGI2) and nitric oxide (NO) to inhibit platelet functions. P...